NCT05570643View on ClinicalTrials.gov

The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 5, 2018

Primary Completion Date

June 28, 2018

Study Completion Date

June 28, 2018

Conditions
Sepsis, Endotoxemia, Immunosuppression
Interventions
DRUG

LPS

This is a non-investigational product. LPS is used as challenge agent to achieve a controlled inflammatory state.

DRUG

Placebo

Injection of NaCl 0.9%.

Trial Locations (1)

6500 HB

Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
collaborator

UMC Utrecht

OTHER

lead

Radboud University Medical Center

OTHER

NCT05570643 - The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells | Biotech Hunter | Biotech Hunter